SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
134 hedge funds and large institutions have $386M invested in Synergy Pharmaceuticals, Inc Common Stock in 2016 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 21
5% more funds holding
Funds holding: 128 → 134 (+6)
Holders
134
Holding in Top 10
2
Calls
$4.64M
Puts
$2.74M
Top Buyers
| 1 | +$63.3M | |
| 2 | +$20.9M | |
| 3 | +$20.6M | |
| 4 |
O
OrbiMed
New York
|
+$14.1M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$11.9M |
Top Sellers
| 1 | -$5.62M | |
| 2 | -$4.66M | |
| 3 | -$3.31M | |
| 4 |
Millennium Management
New York
|
-$2.96M |
| 5 |
FHAM
Folger Hill Asset Management
New York
|
-$2.21M |